Rhian M Touyz, Glaucia E Callera. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Aldosterone/physiologyAngiogenesis Inhibitors/pharmacologyAngiogenesis Inhibitors/therapeutic useAngiotensin II Type 1 Receptor Blockers/pharmacologyAngiotensin II Type 1 Receptor Blockers/therapeutic useAnimalsCapillary Permeability/drug effectsCapillary Permeability/physiologyCattleDiabetic Retinopathy/drug therapyDiabetic Retinopathy/physiopathologyDrug Delivery SystemsHumansMineralocorticoid Receptor Antagonists/pharmacologyMineralocorticoid Receptor Antagonists/therapeutic useNADPH Oxidases/physiologyNeovascularization, Pathologic/physiopathologyNeovascularization, Pathologic/prevention & controlOxidative StressRabbitsRatsReactive Oxygen Species/metabolismReceptors, Mineralocorticoid/physiologyRenin-Angiotensin System/drug effectsRenin-Angiotensin System/physiologyRetinal Vasculitis/drug therapyRetinal Vasculitis/physiopathologyVascular Endothelial Growth Factor A/antagonists & inhibitorsVascular Endothelial Growth Factor A/physiology
Substances： See more » Angiogenesis InhibitorsAngiotensin II Type 1 Receptor BlockersMineralocorticoid Receptor AntagonistsReactive Oxygen SpeciesReceptors, MineralocorticoidVascular Endothelial Growth Factor AAldosteroneNADPH Oxidases
Year: 2009 PMID： 19118282 DOI： 10.1161/CIRCRESAHA.108.191288
Source DB: PubMed Journal: Circ Res ISSN： 0009-7330 Impact factor: 17.367